OTCMKTS:VYCO Vycor Medical (VYCO) Stock Price, News & Analysis $0.08 +0.01 (+10.60%) As of 04/28/2025 12:48 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Vycor Medical Stock (OTCMKTS:VYCO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vycor Medical alerts:Sign Up Key Stats Today's Range$0.07▼$0.0850-Day Range$0.06▼$0.0852-Week Range$0.03▼$0.13Volume41,000 shsAverage Volume19,862 shsMarket Capitalization$2.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.Read More… Receive VYCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address VYCO Stock News HeadlinesVycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 14, 2025 | finance.yahoo.comEQS-News: Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor BaseMarch 13, 2025 | markets.businessinsider.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 29, 2025 | Porter & Company (Ad)Vycor Medical, Inc. (VYCO)January 7, 2023 | finance.yahoo.comMedical Review BoardNovember 1, 2022 | health.usnews.comVycor Medical IncSeptember 8, 2022 | reuters.comVycor Medical Inc (VYCO)December 17, 2021 | nasdaq.comSee More Headlines VYCO Stock Analysis - Frequently Asked Questions How have VYCO shares performed this year? Vycor Medical's stock was trading at $0.0699 at the start of the year. Since then, VYCO stock has increased by 7.4% and is now trading at $0.0751. View the best growth stocks for 2025 here. How were Vycor Medical's earnings last quarter? Vycor Medical, Inc. (OTCMKTS:VYCO) posted its quarterly earnings results on Monday, August, 17th. The medical device company reported ($0.01) EPS for the quarter. The medical device company earned $0.24 million during the quarter. How do I buy shares of Vycor Medical? Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vycor Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vycor Medical investors own include Fly Leasing (FLY), Idera Pharmaceuticals (IDRA), ACADIA Pharmaceuticals (ACAD), Bellicum Pharmaceuticals (BLCM), Canopy Growth (CGC), CorMedix (CRMD) and Drone Aviation (DRNE). Company Calendar Last Earnings8/17/2020Today4/29/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolOTCMKTS:VYCO Previous SymbolOTCMKTS:VYCO CIK1424768 Webwww.vycormedical.com Phone(561) 558-2000Fax631-794-2444Employees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-70,000.00 Net Margins-13.46% Pretax Margin-13.19% Return on EquityN/A Return on Assets-18.94% Debt Debt-to-Equity RatioN/A Current Ratio0.16 Quick Ratio0.12 Sales & Book Value Annual Sales$1.46 million Price / Sales1.72 Cash FlowN/A Price / Cash FlowN/A Book Value($0.10) per share Price / Book-0.75Miscellaneous Outstanding Shares33,373,000Free Float30,318,000Market Cap$2.51 million OptionableNot Optionable Beta-0.04 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (OTCMKTS:VYCO) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vycor Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vycor Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.